Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-131 Tositumomab + R-CHOP in Older Patients with DLBCL
NCT00107380Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Nov 2005
- Primary completion
- Nov 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tositumomab + iodine-131 tositumomab in diffuse large B-cell lymphoma (DLBCL), sponsored by SWOG Cancer Research Network. Started Nov 2005; status: completed.
02
Drugs
tositumomab + iodine-131 tositumomab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00107380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107380.